Synthetic Drugs Reshape Global Health Risks

Emerging patterns of substance use, particularly the rise of synthetic drugs, are creating complex and less predictable health risks worldwide. Global health systems are finding it difficult to adapt to these rapidly evolving drug markets, with limited access to essential treatment and prevention services exacerbating the problem.

An estimated 300 million people used drugs globally in the past year, yet only a small fraction receive necessary care. Barriers such as stigma, discrimination, and criminalization push vulnerable groups, including women and young individuals, away from health services. The misuse of pharmaceuticals for non-medical purposes is also on the rise, adding to the complexity of the challenge.

Health systems, many originally designed for older drug types like heroin, are struggling to cope with combined substance use and new distribution channels. Experts advocate for integrating mental health, substance use, and infectious disease services, especially at the primary care level. Community engagement is crucial for reaching populations most at risk.

Uzbekistan is increasingly viewing drug use as a health and social issue rather than solely a criminal one, highlighting the need for new approaches. The country is working to improve treatment and rehabilitation systems by combining international medical experience and providing integrated care. Strengthening prevention, early detection, and outpatient services are also key priorities.

Central Asian nations are focusing on youth engagement for prevention efforts, given the region's young population. Evidence-based programs aim to raise awareness and equip young people with skills to avoid risky situations. The global shift in understanding drug-related challenges emphasizes addressing underlying health, social, and economic dimensions, requiring adaptable health systems and international cooperation.